SCHEMBL10323988

SCHEMBL10323988

CS(=O)(=O)c1ncc2cc(C(=O)O)c(=O)[nH]c2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
HSD17B10 Q99714 4/20 0.43
GAA P10253 2/20 0.43
HPGD P15428 2/20 0.43
KDM6B O15054 2/20 0.39
KDM4A O75164 2/20 0.39
KDM4D Q6B0I6 2/20 0.39
HIF1AN Q9NWT6 2/20 0.39
KDM2A Q9Y2K7 2/20 0.39
ALDH1A1 P00352 4/20 0.38
POLB P06746 1/20 0.38
DYRK1A Q13627 5/20 0.36
DYRK1B Q9Y463 5/20 0.36
NPC1 O15118 2/20 0.36
MAPT P10636 2/20 0.36
HTT P42858 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
TLR9 Q9NR96 2/20 0.36
LMNA P02545 2/20 0.36
MITF O75030 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10322403 0.80 KDM4E (0.47) KDM4EHSD17B10GAAHPGDKDM6B
SCHEMBL31290945 0.78 PARG (0.35) HSD17B10ALDH1A1NPC1MAPTHTT
SCHEMBL10446512 0.76 KDM4E (0.41) KDM4EHSD17B10GAAHPGDKDM6B
SCHEMBL10323627 0.76 DYRK1A (0.57) KDM4EGAAALDH1A1POLBDYRK1A
SCHEMBL10323760 0.76 KDM6B (0.50) KDM4EHSD17B10GAAHPGDKDM6B
SCHEMBL10323894 0.73 DYRK1A (0.75) DYRK1ADYRK1B
SCHEMBL10446847 0.73 DYRK1A (0.75) DYRK1ADYRK1B
SCHEMBL28937216 0.72 CDK2 (0.42) HSD17B10ALDH1A1NPC1MAPTHTT
SCHEMBL10324034 0.72 KDM4E (0.41) KDM4EHSD17B10GAAHPGDKDM6B
SCHEMBL29755358 0.72 KDM4E (0.41) KDM4EHSD17B10GAAHPGDKDM6B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012098065-A1 PYRIDO PYRIMIDINES FOR USE AS DYRK1 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 WO disclosed
US-20120184542-A1 PYRIDO PYRIMIDINES ANDERSON KEVIN (US) 2012-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184542-A1 PYRIDO PYRIMIDINES TYMS, TYMP, DPYD KDM4E 2024/4885HSD17B10 4275/4885GAA 860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.